Clinico-epidemiological and vaccination profile of patients attending flu clinic of a tertiary health care institution in Eastern India during the third wave of COVID-19 pandemic
DOI:
https://doi.org/10.15584/ejcem.2022.4.2Keywords:
COVID-19, epidemiology, mutation, pandemic, SARS-CoV-2, vaccinationAbstract
Introduction and aim. With the third wave of COVID-19 hitting the country, there is an urgent need to systematically document the clinical-epidemiological and vaccination details of the patients to formulate evidence-based decisions. So, this study was planned to describe the profile of patients attending the flu clinic of a tertiary care hospital in eastern India.
Material and methods. This hospital-based cross-sectional study was done for 6 weeks (Jan-Feb 2022) among 623 patients using a pre-tested, structured questionnaire related to COVID-19. An unadjusted odds ratio was calculated and statistical significance was attributed to a p-value <0.05.
Results. Out of 623 patients, almost 90% of the patients were vaccinated against COVID-19 with at least one dose of any vaccine. Cough (57.8%) was the most common complaint. Patients aged > 60 years and those having one or more than one comorbidity suffered from moderate-severe COVID-19 infection when compared to their counterparts (p<0.001). Also, 2.1% of fully vaccinated, 3.8% of one dose vaccinated and 10.9% of unvaccinated patients suffered from moderate-severe COVID-19.
Conclusion. During the third wave of the COVID-19 pandemic, a smaller number of elderlies compared to the previous two waves were affected indicating age shifting. The severity of COVID-19 was less among vaccinated individuals compared to unvaccinated highlighting the importance of COVID-19 vaccination.
Downloads
References
Virus origin/Origins of the SARS-CoV-2 virus. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/origins-of-the-virus. Accessed September 15, 2022.
Helmy YA, Fawzy M, Elaswad A, Sobieh A, Kenney SP, Shehata AA. The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control. J Clin Med. 2020;9(4):1225. doi: 10.3390/jcm9041225
Sathian B, Banerjee I, Mekkodathil AA, et al. Epidemiologic characteristics, clinical management and Public Health Implications of Coronavirus Disease 2019 (COVID-19) in Pregnancy: A Systematic Review and meta-analysis. Nepal J Epidemiol. 2021;11(4):1103-1125. doi: 10.3126/nje.v11i4.41911
WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int. Accessed July 29, 2022.
India: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data. https://covid19.who.int. Accessed July 29, 2022.
Latest news. https://www.who.int/westernpacific/emergencies/covid-19/news-covid-19. Accessed July 29, 2022.
Surge in cases indicative of third Covid wave in India: Expert - Coronavirus Outbreak News. https://www.indiatoday.in/coronavirus-outbreak/story/surge-in-cases-indicative-of-third-covid-wave-in-india-expert-1895777-2022-01-04. Accessed July 29, 2022.
Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020;215:108427. doi: 10.1016/j.clim.2020.108427
Joshi J, Mishra P, Kamar SB, et al. Clinical Profile of Cases of COVID-19 in Far Western Province of Nepal. J Nepal Health Res Counc. 2020;18(1):135-137. doi: 10.33314/jnhrc.v18i1.2602
Patel C, Palkar S, Doke P, Deshmukh R. A study of the clinico-epidemiological profile of COVID-19 patients admitted in a tertiary care hospital in India. J Clin Diagn Res. 2021:OC09-OC13. doi: 10.7860/JCDR/2021/47688.14757
Aggarwal A, Shrivastava A, Kumar A, Ali A. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi. J Assoc Physicians India. 2020;68(7):19-26.
Zavascki AP, Falci DR. Clinical Characteristics of Covid-19 in China. N Engl J Med. 2020;382(19):1859. doi: 10.1056/NEJMc2005203
Mohan A, Tiwari P, Bhatnagar S, et al. Clinico-demographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India. Indian J Med Res. 2020;152(1&2):61-69. doi: 10.4103/ijmr.IJMR_1788_20
Sample Size Calculator by Raosoft, Inc. http://www.raosoft.com/samplesize.html. Accessed July 29, 2022.
Google Forms. https://docs.google.com/forms/u/0/. Accessed July 29, 2022.
Sharma DL. Clinical Guidance for Management of Adult COVID-19 Patients (Revised: 14/01/2022).
Hasan MJ, Chowdhury SM, Khan MAS, et al. Clinico-epidemiological characteristics of asymptomatic and symptomatic COVID-19-positive patients in Bangladesh. 2020. doi: 10.1101/2020.08.18.20177089
Galasso V, Pons V, Profeta P, Becher M, Brouard S, Foucault M. Gender differences in COVID-19 attitudes and behavior: Panel evidence from eight countries. Proc Natl Acad Sci U S A. 2020;117(44):27285-27291. doi: 10.1073/pnas.2012520117
Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020;25(10). doi: 10.2807/1560-7917.ES.2020.25.10.2000180
Prakash S, Rao R. Course of hospitalization & outcome of covid-19 admissions during second wave of pandemic in a tertiary care institute, Bihar, India. Int J Adv Res. 2021;9(10):86-93. doi: 10.21474/IJAR01/13520
Jain VK, Iyengar KP, Vaishya R. Differences between First wave and Second wave of COVID-19 in India. Diabetes Metab Syndr. 2021;15(3):1047-1048. doi: 10.1016/j.dsx.2021.05.009
Mullol J, Alobid I, Mariño-Sánchez F, et al. The Loss of Smell and Taste in the COVID-19 Outbreak: a Tale of Many Countries. Curr Allergy Asthma Rep. 2020;20(10):61. doi: 10.1007/s11882-020-00961-1
Kapoor M, Panda PK. India’s Second COVID Wave: How is it different from the First Wave? Int J Infect Dis. 2022;116:S50. doi: 10.1016/j.ijid.2021.12.121
Vaccination has kept severe illness, deaths low in third wave: ICMR. The Times of India. https://timesofindia.indiatimes.com/india/vaccination-has-kept-severe-illness-deaths-low-in-third-wave-icmr/articleshow/89026694.cms. Published January 21, 2022. Accessed July 29, 2022.
Rahman S, Rahman MM, Miah M, et al. COVID-19 reinfections among naturally infected and vaccinated individuals. Sci Rep. 2022;12(1):1438. doi: 10.1038/s41598-022-05325-5
Moghadas SM, Vilches TN, Zhang K, et al. The impact of vaccination on COVID-19 outbreaks in the United States. Preprint. medRxiv. 2021;2020.11.27.20240051. doi: 10.1101/2020.11.27.20240051
Kumar G, Mukherjee A, Sharma RK, et al. Clinical profile of hospitalized COVID-19 patients in first & second wave of the pandemic: Insights from an Indian registry based observational study. Indian J Med Res. 2021;153(5-6):619-628. doi: 10.4103/ijmr.ijmr_1628_21
Sanyaolu A, Okorie C, Marinkovic A, et al. Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med. 2020;2(8):1069-1076. doi: 10.1007/s42399-020-00363-4
CDC COVID-19 Response Team. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):343-346. doi: 10.15585/mmwr.mm6912e2
Vardhan H, Kumar A, Shyama S, et al. Clinical Profile and Outcome of Haemodialysis in Patients With COVID-19 – A Single Centre Experience. Cureus. 13(8):e17170. doi: 10.7759/cureus.17170
Zhang L, Liu Y. Potential interventions for novel coronavirus in China: A systematic review. J Med Virol. 2020;92(5):479-490. doi: 10.1002/jmv.25707
Rivera-Izquierdo M, Valero-Ubierna M del C, R-delAmo JL, et al. Sociodemographic, clinical and laboratory factors on admission associated with COVID-19 mortality in hospitalized patients: A retrospective observational study. PLOS ONE. 2020;15(6):e0235107. doi: 10.1371/journal.pone.0235107
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
